CClinicalTrials.gg
CompletedNCT03284359Updated Mar 3, 2021Results posted

Use of Nudges To Enhance Enrollment in Critical Care Research

An interventional study of Pre-Consent Nudge Bundle in Critical Illness, sponsored by University of Pennsylvania. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-03-03.

Sponsored by University of Pennsylvania · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
182
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Difficulties enrolling patients in randomized clinical trials (RCTs) have long been recognized as a major barrier to successful evaluation of medical interventions. This is particularly problematic among intensive care unit (ICU) trials, of which more than one-third do not reach target enrollment. Under-enrollment and selective enrollment reduce RCTs' abilities to answer the research questions, thereby degrading the trials' scientific value and ethics.

Current evidence suggests that financial incentives can ethically increase study enrollment, but this approach can pose large up-front costs to researchers. However, several nonmonetary behavioral interventions, or nudges, may offer novel and easily scalable approaches to increase enrollment in RCTs.

The investigation team propose a 2-arm RCT in 10 ICUs at Penn to test the relative effectiveness of nudges on enrollment rates. Investigators hypothesize that a bundle of nudges during recruitment will increase enrollment rates compared to usual recruitment procedures will increase enrollment.

Investigators will enroll 182 critically ill patients' surrogate decision makers(participants) to engage in recruitment procedures for a simulated RCT comparing two mechanical ventilation weaning protocols among mechanically ventilated patients. Investigators will also measure participants' assessment of risk of the simulated trial after the informed consent process. This work will provide the first empirical evidence regarding the efficacy of inexpensive, scalable nudges to potentially augment enrollment and reduce costs of future clinical trials.

02

Conditions studied

  • Critical Illness

Browse trials for

Keywords

  • Critical Illness
  • Mechanical Ventilation
  • Economics, Behavioral
  • Surrogate decision maker
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Surrogate decision-makers of patients who are:

  1. Patient and surrogate is 18 years of age or older
  2. Surrogate is English-proficient
  3. Patient is mechanically ventilated
  4. Patient is admitted to participating ICU

Exclusion criteria

Exclusion Criteria:

Surrogate decision-makers of patients who are:

  1. Patient is receiving comfort care only
  2. Patient has anticipated extubation in the next 24 hours.
  3. Patient with tracheostomy.
  4. Bedside clinician declines patient participation.
  5. Surrogate decision maker not available to approach prior to patient being extubated.
04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
182 participants (actual)

Study arms

  • Experimental
    Pre-Consent Nudge Bundle

    Arm 1 will be administered a novel pre-consent nudge bundle which incorporates several behavioral economic interventions within a brief survey. Participants will subsequently be asked by the same research personnel to participate in a simulated randomized control trial (RCT) comparing two mechanical ventilation weaning protocols among mechanically ventilated patients. Participants will receive the standard consent form followed by a risk assessment and demographic survey.

    Behavioral: Pre-Consent Nudge Bundle

  • No intervention
    Standard Consent

    Arm 2 will serve as the control arm. Participants will be approached by the research personnel to participate in a simulated RCT comparing two mechanical ventilation weaning protocols among mechanically ventilated patients. Participants will receive a standard consent form as detailed in the Study Instruments section. Following the consent process participants will conduct the same risk assessment survey and demographic survey.

Interventions

  • BehavioralPre-Consent Nudge Bundle

    The pre-consent nudge bundle survey was developed by the study team and incorporates several behavioral interventions into a bundle of 5 types of nudges: (i) injunctive norms; (ii) descriptive norms; (iii) duty of reciprocity; (iv) self-prophecy; and (v) foot-in-the-door. Injunctive norms involve the perception of what behavior is acceptable, while descriptive norms highlight what behaviors others are engaging in. The duty of reciprocity is the sense that one should repeat pro-social behavior for which they have benefited from. The foot-in-the-door nudge involves asking a participant to perform a small request which has a high consent rate followed by a larger request. The bundle consists of six questions and one statement.

05

What researchers measure

Primary outcomes

  1. Consent Rate

    The primary outcome is consent rate for a simulated RCT. This is an easily measurable binary outcome that has the potential for significant impact on future trial recruitment.

    Time frame: Up to 96 hours

Secondary outcomes

  1. Risk Assessment

    Secondarily we will quantitatively assess the participant's assessment of the risk of participating in the simulated RCT. The risk assessment tool has been previously used in the assessment of risk perception of RCT participation in the setting of behavioral economic nudges. The risk assessment will be used to evaluate participants' impressions of the risk of participating in the RCT using a Likert scale ranging from 1 (Not risky at all) to 7 (very risky), as well as 9 comparative questions, each of which asks whether a study procedure was riskier than another risky activity, such as talking on one's cell phone while driving.

    Time frame: Up to 96 hours

06

Results

Posted Mar 3, 2021

Participant flow

Participant flow — Overall Study
MilestonePre-Consent Nudge BundleStandard Consent
Started9389
Completed9389
Not completed00

Outcome measures

PrimaryConsent Rate

The primary outcome is consent rate for a simulated RCT. This is an easily measurable binary outcome that has the potential for significant impact on future trial recruitment.

Time frame:
Up to 96 hours
Reported as:
Count of participants · Participants
Consent Rate
ParticipantsPre-Consent Nudge BundleStandard Consent
Consent Rate2730
SecondaryRisk Assessment

Secondarily we will quantitatively assess the participant's assessment of the risk of participating in the simulated RCT. The risk assessment tool has been previously used in the assessment of risk perception of RCT participation in the setting of behavioral economic nudges. The risk assessment will be used to evaluate participants' impressions of the risk of participating in the RCT using a Likert scale ranging from 1 (Not risky at all) to 7 (very risky), as well as 9 comparative questions, each of which asks whether a study procedure was riskier than another risky activity, such as talking on one's cell phone while driving.

Time frame:
Up to 96 hours
Reported as:
Median · units on a scale
Risk Assessment
units on a scalePre-Consent Nudge BundleStandard Consent
Risk Assessment2 (0 to 5)2 (0 to 5.5)

Adverse events

Collected over Adverse events were monitored during the interaction. Long term adverse events were not evaluated.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Pre-Consent Nudge Bundle0/93 (0%)0/93 (0%)0/93 (0%)
Standard Consent0/89 (0%)0/89 (0%)0/89 (0%)

Baseline characteristics

Intention to treat

Age, Continuous
Age, Continuous(years)Pre-Consent Nudge BundleStandard ConsentTotal
Mean61.3 ± 13.658.6 ± 17.260 ± 15.5
Sex: Female, Male
Sex: Female, Male(Participants)Pre-Consent Nudge BundleStandard ConsentTotal
Female353671
Male5853111
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Pre-Consent Nudge BundleStandard ConsentTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American152338
White7459133
More than one race000
Unknown or Not Reported4711
Length of ICU stay at enrollment
Length of ICU stay at enrollment(Hours)Pre-Consent Nudge BundleStandard ConsentTotal
Mean97.8 ± 73.1114.5 ± 90.6106.2 ± 81.9
07

Study locations

1 site
  • University of Pennsylvania
    Philadelphia, Pennsylvania 19104-6006, United States
08

References and documents

Publications

  • Krutsinger DC, O'Leary KL, Ellenberg SS, Cotner CE, Halpern SD, Courtright KR. A Randomized Controlled Trial of Behavioral Nudges to Improve Enrollment in Critical Care Trials. Ann Am Thorac Soc. 2020 Sep;17(9):1117-1125. doi: 10.1513/AnnalsATS.202003-194OC. PubMed 32441987 ↗

Study documents

  • Protocol, analysis plan and consent form · Apr 1, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT03284359
Lead sponsor
University of Pennsylvania
Responsible party
Sponsor
First posted
Sep 15, 2017
Start date
Feb 19, 2018
Primary completion
Aug 8, 2019
Completion
Aug 8, 2019
Results posted
Mar 3, 2021
Last update
Mar 3, 2021

Study contacts

Katherine Courtright, M.D., M.S.
principal investigator · University of Pennsylvania

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion